drugset / Trial / NCT05605704

Olive Leaf Extracts in the Control of Diabet

NCT05605704 ↗

Phase 2/3 Recruiting 500 enrolled University of Monastir
RandomizedParallel-groupSingle-blindPrevention

Summary

This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital). Patients over 18 years of age with: -Diabets

Timeline

Start
2023-01-01
Primary completion
2025-09-15
Completion
2025-12-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atherolive Unknown 400 mg —